Furthermore, the strong association between patient survival and soluble PD-L1 levels in other malignant diseases [12,13,14,15,16] has led to the recommendation that the soluble PD-L1 level can also be used as a possible prognostic marker in CRC [17]. This evidence concerns the gene CD274 and colorectal carcinoma.